On March 12, 2020, Medicago, a biotechnology company from Quebec, Quebec, reported developing a particle similar to the coronavirus with partial funding from the Canadian Institutes of Health Research.
Tarehe 12 Machi 2020, Medicago, kampuni ya bioteknolojia katika Jiji la Quebec, iliripoti maendeleo ya chembe kama ya virusi vya korona chini ya ufadhili wa sehemi kutoka kwa Taasisi za Kanada za Utafiti wa Afya.